Matches in Wikidata for { <http://www.wikidata.org/entity/Q37285132> ?p ?o ?g. }
- Q37285132 description "2016 թվականի սեպտեմբերի 12-ին հրատարակված գիտական հոդված" @default.
- Q37285132 description "article científic" @default.
- Q37285132 description "article scientifique" @default.
- Q37285132 description "articolo scientifico" @default.
- Q37285132 description "artigo científico" @default.
- Q37285132 description "artículu científicu espublizáu en 2016" @default.
- Q37285132 description "bilimsel makale" @default.
- Q37285132 description "scientific article published on 12 September 2016" @default.
- Q37285132 description "vedecký článok" @default.
- Q37285132 description "vetenskaplig artikel" @default.
- Q37285132 description "videnskabelig artikel" @default.
- Q37285132 description "vědecký článek" @default.
- Q37285132 description "wetenschappelijk artikel" @default.
- Q37285132 description "wissenschaftlicher Artikel" @default.
- Q37285132 description "наукова стаття, опублікована у вересні 2016" @default.
- Q37285132 description "научни чланак" @default.
- Q37285132 description "مقالة علمية نشرت في 12 سبتمبر 2016" @default.
- Q37285132 name "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia." @default.
- Q37285132 name "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia." @default.
- Q37285132 name "EXpanding Treatment for Existing Neurological Disease" @default.
- Q37285132 type Item @default.
- Q37285132 label "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia." @default.
- Q37285132 label "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia." @default.
- Q37285132 label "EXpanding Treatment for Existing Neurological Disease" @default.
- Q37285132 prefLabel "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia." @default.
- Q37285132 prefLabel "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia." @default.
- Q37285132 prefLabel "EXpanding Treatment for Existing Neurological Disease" @default.
- Q37285132 P1433 Q37285132-2185738A-11B5-43F5-92A0-D25075973EFE @default.
- Q37285132 P1476 Q37285132-CBEB1A0C-A0A4-4A7A-99AA-C86479CB2CA5 @default.
- Q37285132 P2860 Q37285132-01085C2A-221C-40DD-A2CB-FE04817FF315 @default.
- Q37285132 P2860 Q37285132-066EC521-800E-4A1B-91C1-AE18D024CAA8 @default.
- Q37285132 P2860 Q37285132-1F34C302-3ECF-4291-9DCC-025DDDBBD655 @default.
- Q37285132 P2860 Q37285132-22FC06C0-3144-4B0C-AABB-7845516CB299 @default.
- Q37285132 P2860 Q37285132-3437293C-1B2C-4377-A16C-339D0B051C1B @default.
- Q37285132 P2860 Q37285132-38FE660A-3C98-4567-AC2A-03CD9BDC82C8 @default.
- Q37285132 P2860 Q37285132-57C517BC-4E4B-4365-9C09-0609FAC0FCB1 @default.
- Q37285132 P2860 Q37285132-5B47CB42-8511-4818-B3ED-CA9A8EBEF6ED @default.
- Q37285132 P2860 Q37285132-5F21C560-A75E-421F-916E-2F835BDF0E06 @default.
- Q37285132 P2860 Q37285132-728349D7-58D6-4E73-84A5-13D495B0C1C8 @default.
- Q37285132 P2860 Q37285132-833315C3-25F9-4679-9744-2938AE29E192 @default.
- Q37285132 P2860 Q37285132-871B1AF9-8E8C-4E0E-93D2-9D5DC6AE514F @default.
- Q37285132 P2860 Q37285132-8D7FA04A-9309-43D1-B898-2E041B1EEB63 @default.
- Q37285132 P2860 Q37285132-92ABA14A-B4EA-47E1-8B0E-A8AC9F14FAAA @default.
- Q37285132 P2860 Q37285132-A0984C13-3057-4992-8FF2-8B3C04DF4B44 @default.
- Q37285132 P2860 Q37285132-B237B4D2-29E7-4A14-967E-A205F5945A36 @default.
- Q37285132 P2860 Q37285132-B36F0964-8BB9-4E31-98D2-5842C927ECBA @default.
- Q37285132 P2860 Q37285132-B4D50FC8-7F2B-4705-AAB8-A1144AF9746A @default.
- Q37285132 P2860 Q37285132-C199977B-01C8-4B5B-A3AE-A461A71C9FAB @default.
- Q37285132 P2860 Q37285132-D5344247-7CC7-45A4-953F-53B8D4137D09 @default.
- Q37285132 P2860 Q37285132-DE3398C1-5594-46F6-B708-031C2EE9FBCE @default.
- Q37285132 P2860 Q37285132-EA9D9E0D-A7E4-4377-BD8B-FED1D460C92F @default.
- Q37285132 P2860 Q37285132-F0FF8A8E-4116-4046-826F-5DA6D4EAC537 @default.
- Q37285132 P2860 Q37285132-FE60B100-630C-4114-B94E-C92A010E6D44 @default.
- Q37285132 P304 Q37285132-D1C91F40-ABA7-43B0-81ED-56CE17792BC6 @default.
- Q37285132 P31 Q37285132-25028AC5-9F06-4CB4-9BD6-20728421E491 @default.
- Q37285132 P356 Q37285132-D9635DCA-9BE9-44EE-8ADD-98FE622CE70F @default.
- Q37285132 P433 Q37285132-A1EA57CA-F6A3-4749-99E0-316A2A908DAD @default.
- Q37285132 P478 Q37285132-0B1D47E3-8F0F-4987-BC0F-107E7F5D7383 @default.
- Q37285132 P50 Q37285132-0500A415-E6C5-45CB-A41A-DBCCC74BE49A @default.
- Q37285132 P50 Q37285132-406AB8D3-99EB-4D29-821A-4550E23021F5 @default.
- Q37285132 P50 Q37285132-45D7C769-76E0-446F-A59B-660E3E4388C5 @default.
- Q37285132 P50 Q37285132-4AB7634F-A755-4047-A408-CDDD75D44A5B @default.
- Q37285132 P50 Q37285132-4C6E9A68-4686-4040-8706-E69A48E8A8B7 @default.
- Q37285132 P50 Q37285132-66B3AA4F-3ADF-4C49-B67F-5428BA68B682 @default.
- Q37285132 P50 Q37285132-74A5FA29-8E64-41BC-8413-719DDA91A233 @default.
- Q37285132 P50 Q37285132-7FE9ECB6-4677-4EDD-A115-79777A6ADE40 @default.
- Q37285132 P50 Q37285132-81735EDC-2153-46B8-B61A-6950D01830DE @default.
- Q37285132 P50 Q37285132-8C924139-5888-4254-9D56-7AA4B96CAB52 @default.
- Q37285132 P50 Q37285132-B8632F70-C273-4A91-B4BE-77E4B91B1BAF @default.
- Q37285132 P50 Q37285132-DBD02008-EBD9-4C02-B39D-301308D3B7C8 @default.
- Q37285132 P577 Q37285132-865A7C37-E65F-4A94-98BA-789E58A2614E @default.
- Q37285132 P698 Q37285132-99CE0543-324A-43BE-8B56-1B5E6CC235D4 @default.
- Q37285132 P921 Q37285132-4C5818C0-5101-46DB-B172-F60367349997 @default.
- Q37285132 P921 Q37285132-AB356C2E-72E3-414F-B994-BBFA8EA72789 @default.
- Q37285132 P921 Q37285132-DBEF372A-F6E5-4440-8DB6-A54B050D7FCC @default.
- Q37285132 P932 Q37285132-3ABFBCF6-329B-4753-BA55-6CE11CC97482 @default.
- Q37285132 P356 RESPROT.5872 @default.
- Q37285132 P698 27619954 @default.
- Q37285132 P1433 Q27724721 @default.
- Q37285132 P1476 "EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia" @default.
- Q37285132 P2860 Q30459060 @default.
- Q37285132 P2860 Q30830149 @default.
- Q37285132 P2860 Q33981601 @default.
- Q37285132 P2860 Q34418529 @default.
- Q37285132 P2860 Q35953361 @default.
- Q37285132 P2860 Q36470602 @default.
- Q37285132 P2860 Q36540250 @default.
- Q37285132 P2860 Q36788867 @default.
- Q37285132 P2860 Q37480741 @default.
- Q37285132 P2860 Q37897246 @default.
- Q37285132 P2860 Q38935184 @default.
- Q37285132 P2860 Q39141874 @default.
- Q37285132 P2860 Q44804332 @default.
- Q37285132 P2860 Q45190220 @default.
- Q37285132 P2860 Q46453889 @default.
- Q37285132 P2860 Q46982076 @default.
- Q37285132 P2860 Q47100582 @default.
- Q37285132 P2860 Q47906551 @default.
- Q37285132 P2860 Q50180616 @default.
- Q37285132 P2860 Q55043495 @default.